CITIGROUP INC - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 114 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.9%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$472
-84.3%
425
-69.7%
0.00%
Q3 2022$3,000
-98.2%
1,402
-97.5%
0.00%
Q2 2022$170,000
+900.0%
56,193
+2128.1%
0.00%
Q1 2022$17,000
-79.3%
2,522
-74.5%
0.00%
Q4 2021$82,000
+74.5%
9,872
+55.0%
0.00%
Q3 2021$47,000
+46.9%
6,369
+36.3%
0.00%
Q2 2021$32,000
+52.4%
4,673
+132.5%
0.00%
Q1 2021$21,000
-32.3%
2,010
-54.7%
0.00%
Q4 2020$31,000
+342.9%
4,434
+434.9%
0.00%
Q3 2020$7,000
-66.7%
829
-72.5%
0.00%
Q2 2020$21,000
-25.0%
3,013
-48.5%
0.00%
Q1 2020$28,000
-36.4%
5,847
+16.4%
0.00%
Q4 2019$44,000
+175.0%
5,022
+6.0%
0.00%
Q3 2019$16,000
-23.8%
4,736
+14.6%
0.00%
Q2 2019$21,000
-19.2%
4,132
-3.1%
0.00%
Q1 2019$26,000
+30.0%
4,266
-29.6%
0.00%
Q4 2018$20,000
-9.1%
6,060
+75.0%
0.00%
Q3 2018$22,000
-82.9%
3,463
-79.5%
0.00%
Q2 2018$129,000
-63.1%
16,868
+8.0%
0.00%
Q1 2018$350,000
+75.0%
15,624
-0.3%
0.00%
Q4 2017$200,000
+545.2%
15,675
+679.9%
0.00%
Q3 2017$31,000
+6.9%
2,010
-3.5%
0.00%
Q2 2017$29,000
-79.3%
2,082
-67.3%
0.00%
Q1 2017$140,0006,3640.00%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TRV GP II, LLC 572,829$1,340,000100.00%
TRV GP III, LLC 1,148,780$2,688,0001.17%
COWEN AND COMPANY, LLC 3,647,430$8,535,0000.82%
Octagon Capital Advisors LP 1,400,000$3,276,0000.56%
Deep Track Capital, LP 4,259,653$9,968,0000.46%
PFM Health Sciences, LP 4,094,488$9,581,0000.35%
RTW INVESTMENTS, LP 5,106,341$11,949,0000.28%
Omega Fund Management, LLC 275,513$645,0000.24%
Monarch Partners Asset Management LLC 228,370$534,0000.16%
Orbimed Advisors 2,928,900$6,854,0000.13%
View complete list of JOUNCE THERAPEUTICS INC shareholders